Evidence map›Paper›PMID 30258040›Full record

ArticlemSphere2018

Bifidobacterial Dominance of the Gut in Early Life and Acquisition of Antimicrobial Resistance.

Diana H Taft, Jinxin Liu, Maria X Maldonado-Gomez, Samir Akre, M Nazmul Huda, S M Ahmad, Charles B Stephensen, David A Mills

Abstract read
In one paragraph

Article in mSphere, 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 70 papers, 2 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
70citing papers in PubMed, 2 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

70 citing papers in PubMed, 2 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Trial
  4. Review
  5. Emergence of coexistingMicrobiology spectrum · 2026
    Article
  6. Review
  7. Health benefits ofFrontiers in microbiology · 2026
    Review
  8. Article
  9. Article
  10. Review
  11. Article
  12. Article
  13. mSystems · 2025
    Article
  14. Abundance ofmSphere · 2025
    Article
  15. Article
  16. Article
  17. Article
  18. Article
  19. Genomic Characterization and Safety Assessment ofJournal of microbiology and biotechnology · 2024
    Article
  20. Article

10 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Diana H TaftDepartment of Food Science and Technology, University of California, Davis, Davis, California, USA.ORCID 0000-0002-9306-9968
Jinxin LiuDepartment of Food Science and Technology, University of California, Davis, Davis, California, USA.
Maria X Maldonado-GomezDepartment of Food Science and Technology, University of California, Davis, Davis, California, USA.
Samir AkreDepartment of Food Science and Technology, University of California, Davis, Davis, California, USA.
M Nazmul HudaNutrition Department, University of California, Davis, Davis, California, USA.
S M AhmadEnteric and Respiratory Infections Unit, Infectious Diseases Division, ICDDR,B, Dhaka, Bangladesh.
Charles B StephensenNutrition Department, University of California, Davis, Davis, California, USA.
David A MillsDepartment of Food Science and Technology, University of California, Davis, Davis, California, USA damills@ucdavis.edu.

Funding

Activation of probiotic bifidobacteria by milk glyansR01AT008759 · NCCIH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GERMAN, BRUCE, LEBRILLA, CARLITO B · 2014 to 2018
$4.2M
Mechanism of Activation of Probiotic Bifidobacteria by Prebiotic Milk GlycansR01AT007079 · NCCIH · UNIVERSITY OF CALIFORNIA AT DAVIS · PI GERMAN, BRUCE, LEBRILLA, CARLITO B · 2012 to 2016
$2.2M
Genome Sequencer FLXS10RR029668 · NCRR · UNIVERSITY OF CALIFORNIA BERKELEY · PI NGAI, JOHN J. · 2010 to 2010
$623k
Illumina Sequencer to Facilitate Functional Genomics at BerkeleyS10RR027303 · NCRR · UNIVERSITY OF CALIFORNIA BERKELEY · PI TAYLOR, JOHN W. · 2010 to 2010
$500k
Effects of Bifidobacterium Dominance on the Infant MicrobiomeF32HD093185 · NICHD · UNIVERSITY OF CALIFORNIA AT DAVIS · PI TAFT, DIANA HAZARD · 2017 to 2020
$218k
NCCIH NIH HHS R01 AT007079NCCIH NIH HHS R01 AT008759NCRR NIH HHS S10 RR027303NCRR NIH HHS S10 RR029668NICHD NIH HHS F32 HD093185
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

Gastrointestinal MicrobiomeAnti-Bacterial AgentsBangladeshBifidobacteriumDNA, BacterialDrug Resistance, BacterialFecesFemaleHumansInfantMaleMetagenomicsProbioticsRegression AnalysisAnti-Bacterial AgentsDNA, Bacterialantimicrobial resistancebifidobacteriagut metagenomeinfant

Identifiers

PMID30258040
PMCPMC6158511

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.